Lymph node-targeted delivery of HIV vaccine candidates
HIV 候选疫苗的淋巴结靶向递送
基本信息
- 批准号:9770530
- 负责人:
- 金额:$ 3.2万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2018
- 资助国家:美国
- 起止时间:2018-09-01 至 2022-08-31
- 项目状态:已结题
- 来源:
- 关键词:AffinityAntibodiesAntibody FormationAntibody RepertoireAntibody ResponseAntigen PresentationAntigen TargetingAntigensAreaB-Cell DevelopmentB-LymphocytesBindingBolus InfusionCD4 Positive T LymphocytesCell CompartmentationCellsCharacteristicsClinicalCoculture TechniquesComplementComplement 3d ReceptorsComplexConfocal MicroscopyDendritic CellsDevelopmentEncapsulatedEndocytosisEpitopesFlow CytometryFollicular Dendritic CellsFormulationGenerationsGlycoproteinsGoalsHIVHIV AntigensHIV vaccineHelper-Inducer T-LymphocyteImmune responseImmunizationImmunization ScheduleImmunoglobulin Somatic HypermutationImmunoliposomeInfectionLinkLiposomesLymphoidMembraneMembrane GlycoproteinsMemoryOrganOryctolagus cuniculusParticulatePhenotypePopulationPreventive vaccineProductionProteinsRoleSamplingSerumStructureStructure of germinal center of lymph nodeSurfaceTechniquesVaccine DesignVaccinesVirusWorkXCR1 genedesignflexibilityglobal healthglycosylationhumanized mouseimprovedin vivoin vivo imaginglymph nodesneutralizing antibodynonhuman primatereceptorrelease of sequestered calcium ion into cytoplasmresponsesample fixationsecondary infectiontargeted deliverytraffickinguptakevaccine candidatevaccine development
项目摘要
PROJECT SUMMARY/ABSTRACT
There is a critical need for a preventative vaccine against human immunodeficiency virus (HIV). Despite
continued structural refinement, immunization with soluble HIV envelope glycoprotein (Env) trimer has yet to
elicit the desired broadly neutralizing antibodies (bNabs). This delay may in part be due to the inefficient delivery
of Env trimer to the follicles of secondary lymphoid organs. The heavy glycosylation of Env, poor complement
fixation, and instability in sera all contribute to inefficient trafficking. Previous work to array Env trimer on the
surface of liposomes has revealed improved antibody responses following immunization. Here we seek to target
Env-displaying liposomes to relevant cell populations native to the lymph node follicle with the goal of increased
neutralizing antibody production. We hypothesize that improved targeting of Env trimer to the lymph node will
bias the antibody repertoire towards neutralizing phenotypes.
This will be accomplished by targeting liposome-bound Env trimer to the two cell populations directing germinal
center (GC) B cell affinity maturation. First, the antigen reservoir of follicular dendritic cells will be targeted,
allowing for continual exposure of GC B cells to neutralizing epitopes. During natural infection, sustained antigen
presentation to GC B cells has been shown to stimulate somatic hypermutation, affinity maturation, and the
development of unusually long heavy chain complementary determining region 3 (HCDR3), characteristic of
bNabs. Second, antigen-specific cognate T follicular helper (Tfh) cell populations will be increased by targeting
immunogen to CLEC9A+XCR1+ dendritic cells, responsible for activating Tfh cells. Previous work has shown that
a large Tfh cell population may reduce competition between neutralizing and non-neutralizing epitope-specific B
cells, favoring the development of neutralizing antibodies. Aim 1 focuses on the delivery of intact Env trimer to
the follicular dendritic cell antigen reservoir, while Aim 2 looks to target delivery to CLEC9A+XCR1+ dendritic cells
with the goal of expanding the antigen specific Tfh cell population. The final Aim looks to characterize the Tfh
and B cell response to immunization with each targeting approach alone and in combination. If successful, this
work will provide a flexible platform for targeted antigen delivery capable of boosting neutralizing antibody
production against HIV.
!
项目总结/文摘
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Geraldine Goebrecht其他文献
Geraldine Goebrecht的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Geraldine Goebrecht', 18)}}的其他基金
Lymph node-targeted delivery of HIV vaccine candidates
HIV 候选疫苗的淋巴结靶向递送
- 批准号:
10011559 - 财政年份:2018
- 资助金额:
$ 3.2万 - 项目类别:
相似海外基金
University of Aberdeen and Vertebrate Antibodies Limited KTP 23_24 R1
阿伯丁大学和脊椎动物抗体有限公司 KTP 23_24 R1
- 批准号:
10073243 - 财政年份:2024
- 资助金额:
$ 3.2万 - 项目类别:
Knowledge Transfer Partnership
Role of Natural Antibodies and B1 cells in Fibroproliferative Lung Disease
天然抗体和 B1 细胞在纤维增生性肺病中的作用
- 批准号:
10752129 - 财政年份:2024
- 资助金额:
$ 3.2万 - 项目类别:
CAREER: Next-generation protease inhibitor discovery with chemically diversified antibodies
职业:利用化学多样化的抗体发现下一代蛋白酶抑制剂
- 批准号:
2339201 - 财政年份:2024
- 资助金额:
$ 3.2万 - 项目类别:
Continuing Grant
Isolation and characterisation of monoclonal antibodies for the treatment or prevention of antibiotic resistant Acinetobacter baumannii infections
用于治疗或预防抗生素耐药鲍曼不动杆菌感染的单克隆抗体的分离和表征
- 批准号:
MR/Y008693/1 - 财政年份:2024
- 资助金额:
$ 3.2万 - 项目类别:
Research Grant
Discovery of novel nodal antibodies in the central nervous system demyelinating diseases and elucidation of the mechanisms through an optic nerve demyelination model
发现中枢神经系统脱髓鞘疾病中的新型节点抗体并通过视神经脱髓鞘模型阐明其机制
- 批准号:
23K14783 - 财政年份:2023
- 资助金额:
$ 3.2万 - 项目类别:
Grant-in-Aid for Early-Career Scientists
Elucidation of the mechanisms controlling the physicochemical properties and functions of supercharged antibodies and development of their applications
阐明控制超电荷抗体的理化性质和功能的机制及其应用开发
- 批准号:
23KJ0394 - 财政年份:2023
- 资助金额:
$ 3.2万 - 项目类别:
Grant-in-Aid for JSPS Fellows
Developing first-in-class aggregation-specific antibodies for a severe genetic neurological disease
开发针对严重遗传神经系统疾病的一流聚集特异性抗体
- 批准号:
10076445 - 财政年份:2023
- 资助金额:
$ 3.2万 - 项目类别:
Grant for R&D
PLA2G2D Antibodies for Cancer Immunotherapy
用于癌症免疫治疗的 PLA2G2D 抗体
- 批准号:
10699504 - 财政年份:2023
- 资助金额:
$ 3.2万 - 项目类别:
Genetic adjuvants to elicit neutralizing antibodies against HIV
基因佐剂可引发抗艾滋病毒中和抗体
- 批准号:
10491642 - 财政年份:2023
- 资助金额:
$ 3.2万 - 项目类别:
Novel Immunogens to Elicit Broadly Cross-reactive Antibodies That Target the Hemagglutinin Head Trimer Interface
新型免疫原可引发针对血凝素头三聚体界面的广泛交叉反应抗体
- 批准号:
10782567 - 财政年份:2023
- 资助金额:
$ 3.2万 - 项目类别: